Search Results - "Mathot R"

Association of graded allele-specific changes in CYP2D6 function with imipramine dose requirement in a large group of depressed patients.

Authors: Schenk, P. W. van Fessem, M. A. C. Verploegh-Van Rij, S. et al.

Source: Molecular Psychiatry. Jun2008, Vol. 13 Issue 6, p597-605. 9p. 2 Charts, 3 Graphs.

Subjects: Mental health, Genetic polymorphisms, Genetic research, Drug therapy, Drug side effects

Relationship between irreversible alopecia and exposure to cyclophosphamide, thiotepa and carboplatin (CTC) in high-dose chemotherapy.

Authors: E. de Jonge, M. A. A. Mathot, R. Dalesio, O. et al.

Source: Bone Marrow Transplantation. 11/1/2002, Vol. 30 Issue 9, p593-597. 5p.

Installation of a power plant of 100 H. P. in factory having large quantities of wood waste available.

Authors: Mathot, R. E.

Source: Journal of the American Society of Mechanical Engineers.; February 1913, Vol. 35, p332-334, 3p

Front axle swivels.

Authors: Mathot, R. E.

Source: Automobile Engineer; July 1925, Vol. 15, p219-221, 3p

Population pharmacokinetics of haloperidol in terminally ill adult patients.

Authors: Franken, L. Mathot, R. Masman, A. et al.

Source: European Journal of Clinical Pharmacology. Oct2017, Vol. 73 Issue 10, p1271-1277. 7p. 2 Charts, 2 Graphs.

Influence of compression in internal-combustion engines.

Authors: Mathot, R. E.

Source: Power; April 11 1916, Vol. 43, p512-514, 3p

Vegetable oils for internal combustion engines.

Authors: Mathot, R. E.

Source: Engineer (00137758); August 5 1921, Vol. 132, p138-139, 2p

Vegetable oils as fuel for internal combustion engines.

Authors: Mathot, R. E. d'Althoff, T.

Source: Engineer (00137758); March 11 1921, Vol. 131, p255-256, 2p

Evolution of the heavy oil engine.

Authors: Mathot, R. E.

Source: Engineer (00137758); February 9 1923, Vol. 135, p137-138, 2p

L'évolution des moteurs 'a huiles lourdes.

Authors: Mathot, R. E.

Source: Memoires et Compte-Rendu des Travaux de la Société des Ingenieurs Civils de France; January 1924, Vol. 77, p143-81, pl

Recalescence of steel.

Authors: Mathot, R. E.

Source: Journal of the Society of Automotive Engineers; April 1926, Vol. 18, p388-388, 1p

Recent progress in internal-combustion engine valve gears.

Authors: Mathot, R. E.

Source: Power; October 30 1917, Vol. 46, p608-609, 2p

Margin of power in internal combustion engines.

Authors: Mathot, R. E.

Source: Power; June 20 1916, Vol. 43, p877-878, 2p

AI tool distinguishes differences in endoscopic disease activity in ulcerative colitis where humans could not: data from the TITRATE trial.

Authors: Gecse, K. B. Oostrom, J. Van Sunny, G. et al.

Source: Journal of Crohn's & Colitis. 2026 Supplement, Vol. 20, pi342-i345. 4p.

Pharmacokinetic and pharmacodynamic evaluation of alternative pomalidomide dosing regimens in the treatment of multiple myeloma.

Authors: Seefat, M. R. Cucchi, D. G. J. van Boven, L. et al.

Source: British Journal of Haematology. Jan2026, Vol. 208 Issue 1, p337-342. 6p.

A comparison of the acid-inhibitory effects of esomeprazole and rabeprazole in relation to pharmacokinetics and CYP2 C19 polymorphism.

Authors: Hunfeld, N. G. Touw, D. J. Mathot, R. A. et al.

Source: Alimentary Pharmacology & Therapeutics. Apr2012, Vol. 35 Issue 7, p810-818. 7p. 1 Chart, 2 Graphs.

A comparison of the acid-inhibitory effects of esomeprazole and pantoprazole in relation to pharmacokinetics and CYP2C19 polymorphism.

Authors: HUNFELD, N. G. TOUW, D. J. MATHOT, R. A. et al.

Source: Alimentary Pharmacology & Therapeutics. Jan2010, Vol. 31 Issue 1, p150-159. 10p. 4 Charts, 4 Graphs.

Potential for improvement of docetaxel-based chemotherapy: a pharmacological review.

Authors: Engels, F. K. Sparreboom, A. Mathot, R. A. A. et al.

Source: British Journal of Cancer. 7/25/2005, Vol. 93 Issue 2, p173-177. 5p.

Nicardipine in pre-eclamptic patients: placental transfer and disposition in breast milk.

Authors: Bartels, P. A. Hanff, L. M. Mathot, R. A. A. et al.

Source: BJOG: An International Journal of Obstetrics & Gynaecology. Feb2007, Vol. 114 Issue 2, p230-233. 4p. 1 Chart, 1 Graph.

Suppression of anti-drug antibodies to infliximab or adalimumab with the addition of an immunomodulator in patients with inflammatory bowel disease.

Authors: Strik, A. S. Brink, G. R. Ponsioen, C. et al.

Source: Alimentary Pharmacology & Therapeutics. Apr2017, Vol. 45 Issue 8, p1128-1134. 7p.